Will Local Market Access Needs Ever Be Met by Global Evidence Packages? LiveSLR to the Rescue
Grammati Sarri, PhD, MSc, DiDS, Cytel, London, LON, UK, Maria Rizzo, MSc, Cytel, London, UK and Julia Gaebler, PhD, Cytel, Cambridge, MA, USA
Regularly updating evidence closer to local submissions along meeting specific population, intervention/comparator, outcomes, and study design (PICOS) requests for each local market remain significant challenges for companies preparing for multiple country submissions that may seriously compromise market access success. Furthermore, these challenges are magnified by a general push by decision-makers for faster patient access to promising health technologies that put pressure to companies to prepare submissions at higher evidentiary standards in a shorter preparation period. This is where LiveSLR® comes to the rescue; we will introduce how an online tool, LiveSLR® which uses automation and by adhering to HTA standards, can store and present the vast quantity of literature as part of a global evidence package, but can easily and transparently filter local relevant evidence based on PICOS and geography. The output from PICOS selection is an automated report with customized study selection criteria, tailored Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow of literature, with data visualization and graphics. By speeding up time-consuming steps in local submissions such as conducting or updating local systematic literature reviews, manufacturers can divert investment in time and resources towards stronger, value-based local market access submissions.
Sponsored by Cytel
Health Technology Assessment